Skip to main content

Breast Cancer Research and Treatment

Ausgabe 1/2017

Inhalt (21 Artikel)

Review

Algorithms for prediction of the Oncotype DX recurrence score using clinicopathologic data: a review and comparison using an independent dataset

Michael R. Harowicz, Timothy J. Robinson, Michaela A. Dinan, Ashirbani Saha, Jeffrey R. Marks, P. Kelly Marcom, Maciej A. Mazurowski

Preclinical study

Use of droplet digital PCR for quantitative and automatic analysis of the HER2 status in breast cancer patients

Kazutaka Otsuji, Takeshi Sasaki, Atsushi Tanaka, Akiko Kunita, Masako Ikemura, Keisuke Matsusaka, Keiichiro Tada, Masashi Fukayama, Yasuyuki Seto

Preclinical study

PD-L1 expression and tumor infiltrating PD-1+ lymphocytes associated with outcome in HER2+ breast cancer patients

Julia Y. S. Tsang, Wai-Ling Au, Kwan-Yin Lo, Yun-Bi Ni, Thazin Hlaing, Jintao Hu, Siu-Ki Chan, Kui-Fat Chan, Sai-Yin Cheung, Gary M. Tse

Preclinical study

Assessment of an APOBEC3B truncating mutation, c.783delG, in patients with breast cancer

Hoda Radmanesh, Tessa Spethmann, Julia Enßen, Peter Schürmann, Sabin Bhuju, Robert Geffers, Natalia Antonenkova, Elza Khusnutdinova, Ariane Sadr-Nabavi, Fatemeh Homaei Shandiz, Tjoung-Won Park-Simon, Peter Hillemanns, Hans Christiansen, Natalia Bogdanova, Thilo Dörk

Preclinical study

Clinical and molecular relevance of mutant-allele tumor heterogeneity in breast cancer

Ding Ma, Yi-Zhou Jiang, Xi-Yu Liu, Yi-Rong Liu, Zhi-Ming Shao

Clinical trial

Recurrence outcomes after omission of postoperative radiotherapy following breast-conserving surgery for ductal carcinoma in situ of the breast: a multicenter, retrospective study in Korea (KROG 16-02)

Kyubo Kim, So-Youn Jung, Kyung Hwan Shin, Jin Ho Kim, Wonshik Han, Han-Byoel Lee, Seung Jae Huh, Doo Ho Choi, Won Park, Seung Do Ahn, Su Ssan Kim, Jin Hee Kim, Chang-Ok Suh, Yong Bae Kim, In Ah Kim, Suzy Kim, Yi-Jun Kim

Clinical trial

Diagnostic performance of tomosynthesis and breast ultrasonography in women with dense breasts: a prospective comparison study

Won Hwa Kim, Jung Min Chang, Joongyub Lee, A Jung Chu, Mirinae Seo, Hye Mi Gweon, Hye Ryoung Koo, Su Hyun Lee, Nariya Cho, Min Sun Bae, Sung Ui Shin, Sung Eun Song, Woo Kyung Moon

Open Access Epidemiology

Volumetric breast density affects performance of digital screening mammography

Johanna O. P. Wanders, Katharina Holland, Wouter B. Veldhuis, Ritse M. Mann, Ruud M. Pijnappel, Petra H. M. Peeters, Carla H. van Gils, Nico Karssemeijer

Epidemiology

Factors contributing to delays in diagnosis of breast cancers in Ghana, West Africa

Louise Brinton, Jonine Figueroa, Ernest Adjei, Daniel Ansong, Richard Biritwum, Lawrence Edusei, Kofi M. Nyarko, Seth Wiafe, Joel Yarney, Beatrice Wiafe Addai, Baffour Awuah, Joe Nat Clegg-Lamptey, Anthony Adjei, Florence Dedey, Verna Vanderpuye, Victoria Okyne, Naomi Ohene Oti, Evelyn Tay, Adu-Aryee, Angela Kenu, Obed Ekpedzor, Francis Aitpillah, Joseph Oppong, Ernest Osei-Bonsu, Nicholas Titiloye, Isaac Boakye, Bernard Arhin, Emmanuel Assimah, Samuel Ka-chungu, Margaret Frempong, Emma Brew Abaidoo, Bridget Nortey Mensah, Samuel Amanama, Prince Agyuapong, Debora Boateng-Ansong, Thomas Agyei, Richard Opoku, Kofi Owusu Gyimah, Stephen Hewitt, Maya Palakal, Jake Thistle, Lisa Newman, Michelle Brotzman, Shelley Niwa, Usha Singh

Epidemiology

Associations of obesity and physical activity with serum and intratumoral sex steroid hormone levels among postmenopausal women with breast cancer: analysis of paired serum and tumor tissue samples

Yoichiro Kakugawa, Hiroshi Tada, Masaaki Kawai, Takashi Suzuki, Yoshikazu Nishino, Seiki Kanemura, Takanori Ishida, Noriaki Ohuchi, Yuko Minami

Epidemiology

Prognostic significance of S100A4-expression and subcellular localization in early-stage breast cancer

Eivind Valen Egeland, Kjetil Boye, Daehoon Park, Marit Synnestvedt, Torill Sauer, Torill Sauer, Jürgen Geisler, Solveig Hofvind, Tone F. Bathen, Elin Borgen, Anne‐Lise Børresen‐Dale, Olav Engebråten, Øystein Fodstad, Øystein Garred, Gry A. Geitvik, Rolf Kåresen, Bjørn Naume, Gunhild M. Mælandsmo, Hege G. Russnes, Ellen Schlichting, Therese Sørlie, Ole C. Lingjærde, Vessela N. Kristensen, Kristine K. Sahlberg, Helle K. Skjerven, Britt Fritzman, Bjørn Naume, Elin Borgen, Gunhild M. Mælandsmo

Epidemiology

Body size from birth through adolescence in relation to risk of benign breast disease in young women

Catherine S. Berkey, Bernard Rosner, Rulla M. Tamimi, Walter C. Willett, Martha Hickey, Adetunji Toriola, A. Lindsay Frazier, Graham A. Colditz

Epidemiology

Psychiatric comorbidities among breast cancer survivors in South Korea: a nationwide population-based study

Jaesung Heo, Mison Chun, Young-Taek Oh, O. Kyu Noh, Logyoung Kim

Epidemiology

Brain metastasis in patients with metastatic breast cancer in the real world: a single-institution, retrospective review of 12-year follow-up

Satomi Matsuo, Junichiro Watanabe, Koichi Mitsuya, Nakamasa Hayashi, Yoko Nakasu, Mitsuhiro Hayashi

Brief Report

Multicenter analysis of neoadjuvant docetaxel, carboplatin, and trastuzumab in HER2-positive breast cancer

Isabel Echavarria, Mónica Granja, Coralia Bueno, Sara Lopez-Tarruella, Paloma Peinado, Miguel Sotelo, Yolanda Jerez, Fernando Moreno, Gabriela Torres, Miriam Lobo, Ivan Marquez-Rodas, Maria Del Monte-Millan, Miguel Martín, Jose Angel García-Saenz

Brief Report

Angiopoietin pathway gene expression associated with poor breast cancer survival

Rajesh Ramanathan, Amy L. Olex, Mikhail Dozmorov, Harry D. Bear, Leopoldo Jose Fernandez, Kazuaki Takabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.